Targeting therapy for prostate cancer by pharmaceutical and clinical pharmaceutical strategies
出版年份 2021 全文链接
标题
Targeting therapy for prostate cancer by pharmaceutical and clinical pharmaceutical strategies
作者
关键词
Prostate cancer, Nanoparticle, Targeting, Combination therapy, Co-delivery
出版物
JOURNAL OF CONTROLLED RELEASE
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-01-13
DOI
10.1016/j.jconrel.2021.01.010
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sorafenib loaded pluronic F127-lithocholic acid micelles for prostate cancer therapy: Formulation, optimization, and in vitro evaluation against LNCaP cells
- (2019) Noha Nasehi et al. International Journal of Polymeric Materials and Polymeric Biomaterials
- Nanoparticle Therapy for Prostate Cancer: overview and perspectives
- (2019) Junfu Zhang et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Self-assembling poly(ethylene glycol)-block-polylactide-cabazitaxel conjugate nanoparticles for anticancer therapy with high efficacy and low in vivo toxicity
- (2019) Qi Shuai et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers
- (2018) Wu Chen et al. ACS Applied Materials & Interfaces
- PET imaging of 64 Cu-DOTA-scFv-anti-PSMA lipid nanoparticles (LNPs): Enhanced tumor targeting over anti-PSMA scFv or untargeted LNPs
- (2017) Patty Wong et al. NUCLEAR MEDICINE AND BIOLOGY
- Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers
- (2016) Long-Bin Cao et al. Nanoscale Research Letters
- Design of folic acid conjugated chitosan nano-cur–bioenhancers to attenuate the hormone-refractory metastatic prostate carcinoma by augmenting oral bioavailability
- (2016) Monika Sharma et al. RSC Advances
- Highly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers
- (2016) Long-Bin Cao et al. Nanoscale Research Letters
- Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells
- (2015) Hai Wang et al. BIOMATERIALS
- Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer
- (2013) Michael E. Werner et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Functionalized Nanoscale Micelles Improve Drug Delivery for Cancer Therapy in Vitro and in Vivo
- (2013) Tuo Wei et al. NANO LETTERS
- Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug
- (2013) X. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Use of Therapeutic Peptides to Target and to Kill Cancer Cells
- (2012) R. J. Boohaker et al. CURRENT MEDICINAL CHEMISTRY
- Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells
- (2010) Paolo Grieco et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
- (2009) Justin P Dassie et al. NATURE BIOTECHNOLOGY
- In vitro photodynamic activity of chloro(5,10,15,20-tetraphenylporphyrinato)indium(III) loaded-poly(lactide-co-glycolide) nanoparticles in LNCaP prostate tumour cells
- (2008) André Romero da Silva et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles
- (2008) S. Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now